Dyadic Announces the Filing of Initial Form 10 Registration Statement with the SEC
JUPITER, FL / ACCESSWIRE / November 5, 2018 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercial scales, today announced that the Company has filed a Form 10 registration statement with the U.S. Securities and Exchange Commission...
Read more









